Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China · Delayed Price · Currency is CNY 59.24
-0.89 (-1.48%)
Sep 9, 2026, 4:00 PM EDT
SHE:301075 Revenue
Tibet Duo Rui Pharmaceutical had revenue of 63.22M CNY in the quarter ending June 30, 2026, with 10.67% growth. This brings the company's revenue in the last twelve months to 143.26M, down -32.30% year-over-year. In the year 2025, Tibet Duo Rui Pharmaceutical had annual revenue of 154.18M, down -35.93%.
Revenue (ttm)
143.26M
Revenue Growth
-32.30%
P/S Ratio
32.65
Revenue / Employee
310.76K
Employees
461
Market Cap
4.68B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 154.18M | -86.45M | -35.93% |
| Dec 31, 2024 | 240.63M | -93.67M | -28.02% |
| Dec 31, 2023 | 334.30M | -66.75M | -16.64% |
| Jan 1, 2023 | 401.05M | -128.57M | -24.28% |
| Jan 1, 2022 | 529.62M | 39.45M | 8.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.